human-immunodeficiency-virus

Documents about human-immunodeficiency-virus

• Assessment of health care workers’ attitudes and perceptions towards voluntary medical male circumcision at Ugu District, KwaZulu-Natal.#323732ResearchSpace
• Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults#390969ClinicalTrials.gov
• A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients#804121ClinicalTrials.gov
• Exploiting the molecular basis of oesophageal cancer for targeted therapies and biomarkers for drug response : guiding clinical decision-making#824447University of Pretoria Repository
• Severe Bacterial Non-AIDS Infections in Persons With Human Immunodeficiency Virus: The Epidemiology and Evolution of Antibiotic Resistance Over an 18-Year Period (2000–2017) in the ANRS CO3 AquiVih-Nouvelle-Aquitaine Cohort#26104HAL (France)
• Characterization of CD8 T cell immune responses directed against cytomegalovirus in people living with human immunodeficiency virus (HIV)#142647HAL (France)
• Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.#831707ClinicalTrials.gov
• Safety and Efficacy of Allogenic Adoptive Immune Therapy for Immune Reconstitution in Chronic HIV-1 Infected Patients#854018ClinicalTrials.gov
• Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]#860581ClinicalTrials.gov
• A Study of Doravirine/Islatravir (DOR/ISL, MK-8591A) for the Treatment of Human Immunodeficiency Virus 1 (HIV-1) Infection in Participants Who Previously Received DOR/ISL (MK-8591A-054)#900726ClinicalTrials.gov
• Pre-exposure Prophylaxis (PrEP) for Health#902941ClinicalTrials.gov
• A case report of Nocardia asiatica constrictive pericarditis in a patient with Human Immunodeficiency Virus#416658University of Pretoria Repository
• Table 1_Single-cell multi-omics reveals circulating B cell heterogeneity across diverse disease contexts.xlsx#424563Figshare
• When Unilateral Leg Swelling is Not Deep Vein Thrombosis: A Case of Disseminated Kaposi Sarcoma Revealing Advanced Human Immunodeficiency Virus#465419ODU Digital Commons
• IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania#845429ClinicalTrials.gov
• Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels#879662ClinicalTrials.gov
• Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)#881310ClinicalTrials.gov
• Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.#883973ClinicalTrials.gov
• Integrating Project YES! With WHO-Endorsed Mental Health Approaches Among Youth Living With HIV#916642ClinicalTrials.gov
• Safety, Tolerability and Immunogenicity Study of Different Vaccine Regimens of Trivalent Ad26.Mos.HIV or Tetravalent Ad26.Mos4.HIV Along With Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults#377269ClinicalTrials.gov
• Data Sheet 1_Single-cell multi-omics reveals circulating B cell heterogeneity across diverse disease contexts.pdf#424564Figshare
• A qualitative exploration of psychosocial determinants influencing viral load suppression among adolescents living with HIV: Application of social action theory#467461African Journals Online
• A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)#876216ClinicalTrials.gov
• A Study to Evaluate Safety, Acceptability, Pharmacokinetics, and ex Vivo Pharmacodynamics of TMC278 Long Acting Formulation in HIV-1 Seronegative Participants#883658ClinicalTrials.gov
• A Multidisciplinary "Integrated Management Team to Improve Maternal-Child Outcomes (IMPROVE)" Intervention to Improve Maternal and Child Outcomes in Lesotho#896970ClinicalTrials.gov
• Utility of the brief Patient Health Questionnaire-2 and Generalized Anxiety Disorder-2 screeners for depression and generalized anxiety symptom identification in people with human immunodeficiency virus.#9940PubMed
• A Phase I, Multicenter, Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules#283082ClinicalTrials.gov
• Severe pneumonia in HIV-infected and exposed infants in a paediatric ICU#339281University of Pretoria Repository
• A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg Dose#346991ClinicalTrials.gov
• Maternal-to-child- transmission of human immunodeficiency virus in maternal preterm premature rupture of the membranes: A Systematic review#372633ULRR
• Immunophenotypic and Molecular Features of TP53 in Diffuse Large B-Cell Lymphoma (DLBCL)#477926WIReDSpace
• Predictive Determinants of Nephrotic Syndrome Remission in Patients With At-risk Polymorphism of APOL1#810761ClinicalTrials.gov
• Intervention to Reduce HIV Related Stigma Among Pregnant and Postpartum Women#969121ClinicalTrials.gov
• Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment#856597ClinicalTrials.gov
• Development Model of Family Empowerment and Peer Group Support in Independence of Caring on Indonesian's Migrant Worker (TKI) Infected by HIV#1004702Jurnal Ners
• A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules#143654ClinicalTrials.gov
• Pre-Approval Access to Rilpivirine Long Acting (RPV LA) Injectable Suspension for the Treatment of a Participant With Human Immunodeficiency Virus (HIV)-1 Infection#858722ClinicalTrials.gov
• An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children#912283ClinicalTrials.gov
• A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients#1030008ClinicalTrials.gov
• Table 1_Multidisciplinary management of severe odontogenic maxillofacial multi-space infection in a patient with HIV–syphilis coinfection and advanced immunosuppression: a case report.docx#635014Figshare
• Study of Doravirine/Islatravir (DOR/ISL 100 mg/0.75 mg) to Evaluate the Antiretroviral Activity, Safety, and Tolerability in Treatment-Naïve Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-020)#803109ClinicalTrials.gov
• Study to Evaluate Switching From an E/C/F/TAF Fixed-Dose Combination (FDC) Regimen or a TDF Containing Regimen to B/F/TAF FDC in Human Immunodeficiency Virus-1 (HIV-1) Infected Participants Aged ≥ 65 Years#904028ClinicalTrials.gov
• Non Invasive Oral Cancer Screening Among HIV Infected Individuals#980532ClinicalTrials.gov
• Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment#836786ClinicalTrials.gov
• A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women#862998ClinicalTrials.gov
• Data Science and Qualitative Research for Decision Support in the HIV Care Cascade#882918ClinicalTrials.gov
• A Study to Assess the Efficacy of Raltegravir (Isentress®), Administered in Combination With Other Antiretroviral Drugs as Treatment for Adults and Older Adults Infected With the Human Immunodeficiency Virus 1 (HIV-1)(MK-0518-145) (Wirksamkeit Von Isentress® Unter Praxisbedingungen)#383495ClinicalTrials.gov
• An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)#849273ClinicalTrials.gov
• A Clinical Study to Evaluate the Safety and Immunogenicity of a Higher Dose of the Study Vaccine, VIR-1388, in HCMV-seropositive Adult Participants Without HIV#868617ClinicalTrials.gov
• Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults#908298ClinicalTrials.gov